Fmoc-L-Asp(tBu)-NH2

Fmoc-L-Asp(tBu)-NH2 is an Fmoc-protected L-aspartamide featuring a side-chain tert-butyl ester (Asp(tBu)) that masks the β-carboxyl group while preserving the stereogenic center of the L-amino acid backbone. The molecule contains an N-fluorenylmethoxycarbonyl (Fmoc) carbamate on the α-amine, enabling orthogonal protection relative to acid-labile side-chain protection. The β-carboxyl functionality is present as a tert-butyl ester, which can be selectively removed under acidic conditions to reveal a reactive carboxylic acid for subsequent coupling or derivatization. The combination of a stable Fmoc group and an acid-labile tBu ester provides a controlled reactivity profile suitable for stepwise peptide assembly and downstream functionalization of aspartyl motifs.

1. Peptide Synthesis

Fmoc-L-Asp(tBu)-NH2 is used in solid-phase peptide synthesis and solution-phase peptide coupling as a protected aspartic acid building block. The Fmoc carbamate supports iterative N-terminal deprotection and re-capping strategies, while the tert-butyl β-ester prevents side-chain participation during chain elongation. The exposed α-amino group after Fmoc removal can be activated for amide bond formation, and the orthogonal side-chain protection enables selective deprotection to generate an Asp side-chain carboxyl for final peptide maturation. Aspartate-containing sequences benefit from this controlled orthogonality for building peptide analogs, generating aspartyl linkages, and preparing peptide intermediates that can be further modified.

2. Side-Chain Functionalization

Fmoc-L-Asp(tBu)-NH2 is applied in amino acid derivatization workflows where β-carboxyl group unveiling and subsequent transformation are required. The tert-butyl ester masks the side-chain carboxyl during handling and coupling, reducing undesired side reactions such as premature acylation or salt formation. Acid-triggered removal of the tBu group can provide a free β-carboxylic acid handle for esterification, amidation, or formation of activated derivatives used in conjugation chemistry. The Fmoc-protected α-amine also supports controlled branching into peptide-like scaffolds or chiral intermediates, enabling downstream construction of carboxyl-functional aspartate derivatives for chemical biology and materials-oriented linkers.

3. Unnatural Amino Acid Incorporation

Fmoc-L-Asp(tBu)-NH2 serves as a stereochemically defined chiral amino acid intermediate for incorporating aspartate-like motifs into peptide-based systems and peptidomimetic structures. The L-configuration at the α-carbon and the protected functional groups support compatibility with coupling chemistries used for unnatural amino acid analog assembly. The orthogonal protection pattern allows the β-carboxyl to be revealed at a chosen stage, supporting the design of analogs where side-chain acidity, spacing, or charge presentation is tuned. The resulting aspartyl-functional scaffolds can be used to probe structure-function relationships in synthetic peptide libraries and to generate defined chiral intermediates for further medicinal chemistry-style elaboration.

4. Bioconjugation Chemistry

Fmoc-L-Asp(tBu)-NH2 is utilized in bioconjugation and biomolecule labeling strategies that require a controlled carboxyl-bearing amino acid motif. The tert-butyl ester provides a protected β-carboxyl that can be unmasked to generate a reactive acid for coupling to amine-bearing biomolecules or for conversion into activated ester or amide-forming intermediates. The Fmoc group supports preparation of conjugation-ready peptide fragments with defined termini, enabling attachment through the aspartyl side-chain rather than uncontrolled random modification. The stereodefined L-aspartate geometry and the orthogonal deprotection logic help maintain structural fidelity in conjugates used for chemical biology studies, affinity reagent construction, and analytical probe generation.

5. Pharmaceutical Intermediate Preparation

Fmoc-L-Asp(tBu)-NH2 is relevant to pharmaceutical intermediate preparation where protected amino acid derivatives are manufactured for downstream synthesis of peptide-like active ingredients or related intermediates. The Fmoc carbamate and tert-butyl ester protection scheme aligns with common orthogonal protection strategies used in process chemistry to control functional group reactivity during multi-step assembly. The molecule's defined stereochemistry supports consistent formation of aspartyl amide linkages and predictable deprotection sequences, which can be leveraged when designing scalable synthetic routes for fine chemicals. The resulting protected aspartate building block can feed into API-adjacent synthesis, peptidomimetic construction, and controlled generation of carboxyl-functional intermediates used in specialty chemical production.

1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

2. High fat diet and GLP-1 drugs induce pancreatic injury in mice

3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

4. The spatiotemporal control of signalling and trafficking of the GLP-1R

5. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis